Canada markets closed

DiaMedica Therapeutics Inc. (DMAC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.93-0.62 (-7.25%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 5148.97M
Enterprise Value 3137.16M
Trailing P/E N/A
Forward P/E 1-5.32
PEG Ratio (5 yr expected) 1-0.35
Price/Sales (ttm)N/A
Price/Book (mrq)6.43
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7-9.87

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3123.82%
S&P500 52-Week Change 344.45%
52 Week High 310.88
52 Week Low 33.24
50-Day Moving Average 39.49
200-Day Moving Average 38.07

Share Statistics

Avg Vol (3 month) 3113.81k
Avg Vol (10 day) 396.3k
Shares Outstanding 518.79M
Implied Shares Outstanding 6N/A
Float 16.4M
% Held by Insiders 17.90%
% Held by Institutions 134.94%
Shares Short (Apr. 14, 2021) 4186.97k
Short Ratio (Apr. 14, 2021) 41.92
Short % of Float (Apr. 14, 2021) 41.07%
Short % of Shares Outstanding (Apr. 14, 2021) 41.00%
Shares Short (prior month Mar. 14, 2021) 4156.75k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov. 14, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Nov. 14, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Mar. 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-44.92%
Return on Equity (ttm)-73.98%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -13.89M
Net Income Avi to Common (ttm)-13.49M
Diluted EPS (ttm)-0.79
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.4M
Total Cash Per Share (mrq)1.25
Total Debt (mrq)102k
Total Debt/Equity (mrq)0.44
Current Ratio (mrq)20.54
Book Value Per Share (mrq)1.23

Cash Flow Statement

Operating Cash Flow (ttm)-1.34B
Levered Free Cash Flow (ttm)-12.93M